Iqirvo

elafibranor

Approval

ApplicationNDA 218860
Approval dateJun 10, 2024
Approval year2024
SponsorIpsen

FDA-approved use

To treat primary biliary cholangitis in combination with ursodeoxycholic acid

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Iqirvo: